World Neurosurg
-
Review Case Reports
Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community.
The coronavirus disease of 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently been designated a pandemic by the World Health Organization, affecting 2.7 million individuals globally as of April 25, 2020, with more than 187,000 deaths. An increasing body of evidence has supported central nervous system involvement. ⋯ The present review has consolidated the current body of data regarding the neurological impact of coronaviruses, discussed the reported neurological manifestations of COVID-19, and highlighted the recommendations for patient management. Specific recommendations pertaining to clinical practice for neurologists and neurosurgeons have also been provided.
-
A 37-year-old man presented with a 7-year history of low back pain. Magnetic resonance imaging revealed an intradural mass involving L5 vertebra impairment at the level of L4-L5. A L4-S1 laminectomy was performed. ⋯ Unlike other spinal cord SFT/HPCs in lumbar area, we firstly reported the case with invasive growth and bone structure impairment. The patient had a good prognosis after 3-year follow-up. Complete resection should be achieved to reduce the recurrence.
-
Sphenoid wing meningiomas (SWMs) can be treated with complete surgical resection and the recently introduced endoscopic transorbital approach (ETOA) offers a minimally invasive alternative. In this study, the surgical outcome of ETOA and the extended mini-pterional approach (eMPTA) for SWMs with osseous involvement is compared. ⋯ ETOA can provide direct access to the sphenoid bone and resectability with a more rapid and minimally invasive exposure than does eMPTA. Maximal subtotal resection with extensive sphenoid bone decompression for tumors with cavernous sinus infiltration is the key to a good clinical outcome, regardless of the surgical approach.